Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid.
The global average price of Antacid is in the decreasing trend, from 11.43 USD/Unit in 2013 to 10.73 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Antacid includes Proton Pump Inhibitor, H2 Antagonist and Acid Neutralizers, and the proportion of Proton Pump Inhibitor in 2017 is about 39%.
According to this study, over the next five years the Antacid market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 6300 million by 2024, from US$ 6120 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antacid business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Antacid market by product type, application, key manufacturers and key regions and countries.
This study considers the Antacid value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
OTC Drug
Rx Drug
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter?Gamble
GlaxoSmithKline
Johnson?Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Antacid consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Antacid market by identifying its various subsegments.
Focuses on the key global Antacid manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antacid with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antacid submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
